A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Key facts
- Who runs it
- BioNTech SE
- Where
- Anaheim, Brownsville, Charlottesville, Chesterfield, Columbus, Doral, East Syracuse, Hialeah, Honolulu, Houston, Knoxville, Lake Forest, Mesquite, Miami, Miami Lakes, Milford, Nashville, North Charleston, North Las Vegas, Philadelphia, Riverside, Rochester, Salt Lake City, San Diego, Seattle, Stockbridge, Tomball, Walnut Creek, and Wilmington, United StatesSee the 30 sites
- Trial code
- Status
- Completed
- Phase
- Phase 1/2
- People taking part
- 2,650 people enrolled
- Started
- 10 Feb 2025
- Ended
- 17 Dec 2025
- Type of study
- Interventional, 30 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Investigational Influenza Vaccine
- Investigational COVID-19 Vaccine
- Investigational Influenza and COVID-19 Combination Vaccine
- Licensed Influenza Vaccine 1
- Licensed Influenza Vaccine 2
- Licensed Influenza Vaccine 3
- Licensed COVID-19 Vaccine
- Record updated
- 26 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Participants 18 years of age or older
- Healthy participants who are determined by medical history, physical examination (if clinically required), and clinical judgement of the investigator to be eligible for inclusion in the study
Who cannot take part
- Vaccination with any investigational or licensed influenza vaccine within 150 days of enrollment
- Receipt of antiviral therapies for influenza (eg, Tamiflu) within 180 days prior to Day 1; Refer to the study contact for further eligibility details
- Vaccination with any investigational or licensed COVID 19 vaccine within 150 days of enrollment
Where in United States
- Anaheim Clinical Trials, LLCAnaheim, United States
- Headlands Horizons, LLC dba Headlands Research-BrownsvilleBrownsville, United States
- Charlottesville Medical ResearchCharlottesville, United States
- Clinical Research ProfessionalsChesterfield, United States
- Centricity Research Columbus Ohio MultispecialtyColumbus, United States
- Alliance for Multispecialty Research, LLCDoral, United States
- Upstate Global Health InstituteEast Syracuse, United States
- Indago Research & Health Center, IncHialeah, United States
- East-West Medical Research InstituteHonolulu, United States
- DM Clinical Research- CyfairHouston, United States
- AMR ClinicalKnoxville, United States
- Orange County Research CenterLake Forest, United States
- SMS Clinical ResearchMesquite, United States
- Miami Dade Medical Research Institute, LLCMiami, United States
- Palm Springs Community Health CenterMiami Lakes, United States
- Clinical Research ConsultingMilford, United States
- Clinical Research Associates, Inc.Nashville, United States
- Coastal Carolina Research CenterNorth Charleston, United States
- Las Vegas Clinical TrialsNorth Las Vegas, United States
- DM Clinical Research - PhiladelphiaPhiladelphia, United States
- Artemis Institute for Clinical ResearchRiverside, United States
- University of Rochester Medical CenterRochester, United States
- J. Lewis Research, Inc. / Foothill Family ClinicSalt Lake City, United States
- J. Lewis Research, Inc. / Foothill Family Clinic SouthSalt Lake City, United States
- Artemis Institute for Clinical ResearchSan Diego, United States
- Kaiser Permanente Washington Health Research Institute (KPWHRI)Seattle, United States
- Clinical Research AtlantaStockbridge, United States
- Dynamed Clinical Research, LP d/b/a DM Clinical ResearchTomball, United States
- Diablo Clinical Research, Inc.Walnut Creek, United States
- Trial Management Associates - Wilmington - Floral ParkwayWilmington, United States
About the trial
What the trial wants to find out
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.
Read full original descriptionShow less
This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
The 30 groups in the trial
- Arm ATreatment being tested
Low Dose COVID-19 Vaccine (1a)
Treatment: Investigational COVID-19 Vaccine
- Arm BTreatment being tested
Low Dose COVID-19 Vaccine ( 1b)
Treatment: Investigational COVID-19 Vaccine
- Arm CTreatment being tested
Low Dose COVID-19 Vaccine ( 1c)
Treatment: Investigational COVID-19 Vaccine
- Arm DTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 1)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm ETreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm FTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm GTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm HExisting treatment, for comparison
Licensed COVID-19 Vaccine
Treatment: Licensed COVID-19 Vaccine
- Arm IExisting treatment, for comparison
Licensed Influenza Vaccine (1)
Treatment: Licensed Influenza Vaccine 1
- Arm JTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm KTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm LTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm MExisting treatment, for comparison
Licensed COVID-19 Vaccine
Treatment: Licensed COVID-19 Vaccine
- Arm NExisting treatment, for comparison
Licensed Influenza Vaccine (2)
Treatment: Licensed Influenza Vaccine 2
- Arm AATreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm BBTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm CCTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm DDTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm EETreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm FFExisting treatment, for comparison
Licensed COVID-19 Vaccine
Treatment: Licensed COVID-19 Vaccine
- Arm GGExisting treatment, for comparison
Licensed Influenza Vaccine (3)
Treatment: Licensed Influenza Vaccine 3
- Arm HHExisting treatment, for comparison
Licensed Influenza Vaccine (2)
Treatment: Licensed Influenza Vaccine 2
- Arm IITreatment being tested
Low Dose COVID-19 Vaccine ( 1b)
Treatment: Investigational COVID-19 Vaccine
- Arm JJTreatment being tested
Low Dose COVID-19 Vaccine ( 1c)
Treatment: Investigational COVID-19 Vaccine
- Arm KKTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm LLTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm MMTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm NNTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm OOTreatment being tested
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5)
Treatment: Investigational Influenza and COVID-19 Combination Vaccine
- Arm PPTreatment being tested
Medium Dose Investigational Influenza Vaccine (1)
Treatment: Investigational Influenza Vaccine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
- Record updated
- 26 January 2026